Medpace Holdings, Inc. MEDP | NASDAQ

$337.28 $2.13 | 0.64%

After Hours
$345.06 $7.78 | 2.31%

Company Overview:

Market Cap: $10.48B
PE Ratio: 29.51
52-Week Range: $277.72 - $459.77
Dividend Yield (FWD): 0.00% ($0.00)

5.9 Year Performance Metrics:

Total Return (with DRIP): 423.73% (32.40% / yr)
Total Return (no DRIP): 423.73% (32.40% / yr)
Share Price: 423.73%
Dividend Increase: nan%
MEDP 5.9-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

MEDP Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
MEDP Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
MEDP Price CAGR:1Y: 11.26%2Y: 28.67%5Y: 31.92%10Y: 18.01%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

MEDP Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - MEDP
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - MEDP
14-Day FREE Trial Get Full Access Now!

MEDP Earnings, Revenue, Cash & Debt, Shares Outstaning:

MEDP - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
MEDP - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
MEDP - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
MEDP - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
MEDP - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
MEDP - Cash & Debt
14-Day FREE Trial Get Full Access Now!
MEDP - Revenue
14-Day FREE Trial Get Full Access Now!
MEDP Revenue CAGR:1Y: 8.29%2Y: 17.89%5Y: 19.79%10Y: N/A
MEDP - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
MEDP EPS CAGR:1Y: 35.59%2Y: 21.17%5Y: 36.72%10Y: N/A
MEDP - Net Income
14-Day FREE Trial Get Full Access Now!
MEDP Net Income CAGR:1Y: 36.77%2Y: 20.89%5Y: 32.16%10Y: N/A
MEDP - EBITDA
14-Day FREE Trial Get Full Access Now!
MEDP EBITDA CAGR:1Y: 40.04%2Y: 18.95%5Y: 29.43%10Y: N/A
MEDP - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
MEDP Free Cash Flow CAGR:1Y: 31.09%2Y: 16.94%5Y: 18.97%10Y: N/A
MEDP - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
MEDP Free Cash Flow / Share CAGR:1Y: 29.32%2Y: 16.87%5Y: 22.50%10Y: N/A
MEDP - Gross Profit
14-Day FREE Trial Get Full Access Now!
MEDP Gross Profit CAGR:1Y: 26.89%2Y: 19.16%5Y: 21.37%10Y: N/A
MEDP - Expenses
14-Day FREE Trial Get Full Access Now!
MEDP Expenses CAGR:1Y: 21.07%2Y: 21.15%5Y: 11.33%10Y: N/A
MEDP - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
MEDP Shares Outstanding CAGR:1Y: 1.03%2Y: -0.26%5Y: -3.24%10Y: N/A
MEDP - Share Buybacks
14-Day FREE Trial Get Full Access Now!
MEDP Share Buybacks CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
MEDP - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
MEDP Stock-Based Comp CAGR:1Y: 134.21%2Y: 42.27%5Y: 4.38%10Y: N/A
MEDP - Dividends
14-Day FREE Trial Get Full Access Now!
MEDP Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
MEDP - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
MEDP Revenue CAGR:1Y: 8.29%2Y: 17.89%5Y: 19.79%10Y: N/A

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MEDP - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MEDP Actual Revenue CAGR:1Y: 8.29%2Y: 17.89%5Y: 19.79%10Y: N/A
MEDP - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MEDP Actual EPS CAGR:1Y: 35.59%2Y: 21.17%5Y: 36.72%10Y: N/A
MEDP - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MEDP Actual Net Income CAGR:1Y: 36.77%2Y: 20.89%5Y: 32.16%10Y: N/A
MEDP - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MEDP Actual EBITDA CAGR:1Y: 40.04%2Y: 18.95%5Y: 29.43%10Y: N/A

Ratios, Profit Margins & Return on Capital:

MEDP - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
MEDP Net Profit Margin CAGR:1Y: 26.26%2Y: 2.56%5Y: 10.27%10Y: N/A
MEDP - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
MEDP Gross Profit Margin CAGR:1Y: 17.20%2Y: 1.07%5Y: 1.33%10Y: N/A
MEDP - Price to Earnings
14-Day FREE Trial Get Full Access Now!
MEDP - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
MEDP - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
MEDP - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

MEDP Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

MEDP Dividend History: Dates, Payments & Yield list

Below is a schedule of all MEDP dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for MEDP

Based on past 5.9-year performance, here are MEDP growth metrics:

Share price CAGR of +31.92%
Dividend CAGR of +0%
Using MEDP CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

MEDP
Current Price$337.28
Start Shares29.65
Start Value$10,000
 
After 10 years:
Final Share Count29.65
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$4,081.05
Total Dividends$0
Final Value$120,999

Estimated Future Value + Dividends - MEDP

NOTE: Above numbers are our estimate based on MEDP's Dividend and Price CAGR over past 5.9 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Medpace Holdings, Inc. (MEDP) had its IPO on 2016-08-11, and is trader on NASDAQ stock exchange.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

MEDP website: https://www.medpace.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial